Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of AQW051 in Patients With Memory Impairment

This study has been terminated.
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals ) Identifier:
First received: December 21, 2007
Last updated: April 15, 2016
Last verified: April 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Primary Completion Date: February 2009 (Final data collection date for primary outcome measure)